Anzeige
Mehr »
Login
Freitag, 23.04.2021 Börsentäglich über 12.000 News von 660 internationalen Medien
Ist das Joe Bidens Lieblingsaktie und zugleich das Übernahmeziel Nr. 1?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DJR2 ISIN: SE0009268717 Ticker-Symbol: 7AC 
Frankfurt
23.04.21
09:40 Uhr
0,129 Euro
-0,002
-1,23 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
ACARIX AB Chart 1 Jahr
5-Tage-Chart
ACARIX AB 5-Tage-Chart

Aktuelle News zur ACARIX Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiAcarix AB: Acarix publishes the annual report for 2020151Press releaseMalmö, Sweden, April 20, 2021 Acarix publishes the annual report for 2020 Today, Tuesday April 20, Acarix is publishing its Annual Report for 2020 on the company website...
► Artikel lesen
12.04.Notice of Annual General Meeting in Acarix AB218Notice of Annual General Meeting in Acarix AB The shareholders of Acarix AB, reg. no. 559009-0667, (the "Company"), are hereby convened to the annual general meeting to be held on Tuesday...
► Artikel lesen
ACARIX Aktie jetzt für 0€ handeln
07.04.Acarix AB: Positive, long term prognostic data from the Dan-NICAD I study published in European Heart Journal- Digital Health208Press releaseMalmö, Sweden, April 7, 2021 Positive, long term prognostic data from the Dan-NICAD I study published in European Heart Journal- Digital Health Acarix AB (publ)...
► Artikel lesen
18.02.Acarix AB: A strong ending of an eventful year280Press release (MAR) Malmö, February 18, 2021 Acarix AB (publ) publishes Year-End Report 2020 A strong ending of an eventful year The fourth quarter contributed strongly to our overall...
► Artikel lesen
13.01.Acarix AB: Positive preliminary data from Acarix's exploratory heart failure study SEISMO295Press release Malmö, Sweden, January 13, 2021 Positive preliminary data from Acarix's...
► Artikel lesen
09.12.20Acarix AB: Acarix announces the last patient included in Dan-NICAD II study314Press release Malmö, Sweden December 9, 2020 Acarix announces the last patient included in Dan-NICAD II study After the inclusion of 1726 patients, Acarix announces that the last patient...
► Artikel lesen
26.11.20Acarix AB: FDA identifies exclusive code for the CADScor336Press release (MAR)Malmö, Sweden, November 26, 2020 FDA identifies exclusive code for the CADScor After yesterday's announcement and further analysis of the FDA approval, Acarix AB today announce...
► Artikel lesen
25.11.20Acarix AB: Acarix receives US market approval for the CADScor System302Press release (MAR)Malmö, Sweden November 25, 2020 Acarix receives US market approval for the CADScor System Acarix AB (publ) today announced that the US Food and Drug Administration (FDA)...
► Artikel lesen
18.11.20Acarix AB: Positive results from Acarix study presented at ISPOR, a leading health economics conference397Press releaseMalmö, Sweden November 18, 2020 Positive results from Acarix study presented at ISPOR, a leading health economics conference Acarix AB (publ) today announced that the company's...
► Artikel lesen
12.11.20Acarix AB: Acarix publishes Interim Report, January - September 2020453Press release (MAR) Malmö, November 12, 2020 Acarix AB (publ) publishes Interim Report, January - September 2020 A Successful Rights Issue with Focus on Sales! During the third quarter,...
► Artikel lesen
15.10.20Acarix AB: Acarix changes Certified Advisor to Redeye271Press release Malmö, Sweden October 15, 2020 Acarix changes Certified Advisor to Redeye Acarix AB (publ) announces today that the company has entered into an agreement with Redeye AB regarding...
► Artikel lesen
29.09.20Acarix AB: Acarix carries out a directed issue of shares to guarantors in conjunction with the oversubscribed rights issue294Press release Malmö, Sweden September 29, 2020 Acarix carries out a directed issue of shares to guarantors in conjunction with the oversubscribed rights issue Acarix AB ("Acarix" or the...
► Artikel lesen
28.09.20Nasdaq Stockholm AB: Last day of trading in paid subscription shares (BTA) of Acarix AB (427/20)831Trading in Acarix AB paid subscription shares is to cease. The last trading day is October 1, 2020. Short name: ACARIX BTA --------------------------- ISIN code: SE0014730735 --------------------------- Orderbook...
► Artikel lesen
28.09.20Acarix AB: Last day of trading in paid subscribed shares (Sw. BTA)299Press release Malmö, Sweden September 28, 2020 Last day of trading in paid subscribed shares (Sw. BTA) Last day of trading in subscribed paid shares ("BTA") in Acarix AB ("Acarix" or the...
► Artikel lesen
11.09.20Acarix AB: Acarix announce final outcome in oversubscribed rights issue337Press release Malmö, Sweden September 11, 2020 Acarix announce final outcome in oversubscribed rights issue Acarix AB ("Acarix" or the "Company") has completed the new share issue...
► Artikel lesen
09.09.20Acarix AB: Acarix announces preliminary outcome in oversubscribed rights issue322Press release Malmö, Sweden September 9, 2020 Acarix announces preliminary outcome in oversubscribed rights issue INSIDE INFORMATION: The preliminary result of the rights issue in Acarix...
► Artikel lesen
03.09.20Acarix AB: Acarix publishes a supplement to the prospectus546Press releaseMalmö, Sweden September 3, 2020 Acarix publishes a supplement to the prospectus The board of directors of Acarix AB ("Acarix" or the "Company") has prepared a supplement to the...
► Artikel lesen
03.09.20Acarix AB: Acarix progresses with the German authorities324Press releaseMalmö, Sweden September 3, 2020 Acarix progresses with the German authorities Acarix AB (publ) today announced that the German Ministry of Health has stated that phonocardiography...
► Artikel lesen
02.09.20Acarix AB: Acarix two largest shareholders transfer subscription rights free of charge - extends the subscription period335Press release Malmö, September 2, 2020 Acarix two largest shareholders transfer subscription rights free of charge -extends the subscription period The Extraordinary General...
► Artikel lesen
20.08.20Nasdaq Stockholm AB: Listing of subscription rights and paid subscription shares of Acarix AB (376)271With effect from August 21, 2020, the subscription rights in Acarix AB will be traded on First North Premier Growth Market. Trading will continue up until and including September 02, 2020. Instrument:...
► Artikel lesen
Seite:  Weiter >>
27 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1